Somalia launches pentavalent vaccine with support from GAVI, UNICEF, WHO

NewsGuard 100/100 Score

"Coinciding with World Immunization Week, the Somali government announced on 24 April its intention to vaccinate all children under the age of one with a new five-in-one vaccine, known as a pentavalent vaccine, funded by the GAVI Alliance, with [UNICEF] and the [WHO] as implementing partners," IRIN reports. "Currently, fewer than half of children in Somalia have received the mandatory diphtheria, tetanus and pertussis (DTP) vaccine," but "[t]he pentavalent will protect immunized children against these three diseases, as well as hepatitis B and Haemophilius influenzae type B," according to the news service (4/26). "President Hassan Sheikh Mohamud, speaking at the new vaccine's launch in Mogadishu on Wednesday, said all Somali children deserve the good health that children from rich countries enjoy," Bloomberg Businessweek writes, adding, "He blamed much of the country's vaccination problem on al-Shabab, the al-Qaida-linked militant group that controls much of south-central Somalia and up until August 2011 controlled Mogadishu" (Straziuso, 4/25). A GAVI Alliance press release notes, "The launch of the vaccine is being accompanied by an outreach campaign to make parents aware of the importance of the new vaccine which replaces the DTP vaccine for diphtheria, tetanus and pertussis (whooping cough)" (4/23).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oxford University and Brazil partner to advance malaria vaccine development